← Back to Search

Hormone Therapy

Insulin Cardioplegia for Heart Failure

N/A
Waitlist Available
Led By Terrence M. Yau
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient has been referred for isolated coronary bypass surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Study Summary

This trial is testing a new method to improve heart function and recovery after bypass surgery in patients with poor pre-operative heart function.

Who is the study for?
This trial is for patients with poor heart function (ejection fraction less than 40%) who are scheduled for coronary bypass surgery. It's not open to those needing additional procedures, minimally invasive surgery, recent heart attack survivors, reoperation cases, or if their heart function has improved recently.Check my eligibility
What is being tested?
The study aims to improve recovery of heart metabolism and function after bypass surgery in patients with weak hearts using a method called Insulin Cardioplegia.See study design
What are the potential side effects?
While the specific side effects aren't listed here, generally speaking, interventions like Insulin Cardioplegia could potentially cause changes in blood sugar levels and may affect how the heart muscle responds post-surgery.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am referred for surgery to improve blood flow to my heart.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Low Output Syndrome
Secondary outcome measures
Total Troponin I Release

Find a Location

Who is running the clinical trial?

Canadian Institutes of Health Research (CIHR)OTHER_GOV
1,336 Previous Clinical Trials
25,750,656 Total Patients Enrolled
1 Trials studying Left Ventricular Dysfunction
2 Patients Enrolled for Left Ventricular Dysfunction
University Health Network, TorontoLead Sponsor
1,460 Previous Clinical Trials
482,544 Total Patients Enrolled
2 Trials studying Left Ventricular Dysfunction
24 Patients Enrolled for Left Ventricular Dysfunction
Terrence M. YauPrincipal Investigator21st Century Cardiac Surgical Society, Council on Cardiovascular and Thoracic Surgery (American Heart Association), Canadian Cardiovascular Society, Royal College of Physicians and Surgeons, Institute of Medical Sciences (University of Toronto)

Media Library

Insulin Cardioplegia (Hormone Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT00188994 — N/A
Left Ventricular Dysfunction Research Study Groups:
Left Ventricular Dysfunction Clinical Trial 2023: Insulin Cardioplegia Highlights & Side Effects. Trial Name: NCT00188994 — N/A
Insulin Cardioplegia (Hormone Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT00188994 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacant slots remaining for potential participants to join this trial?

"As reported on clinicaltrials.gov, the present recruitment for this trial is inactive. It was initially posted in August 1999 and its last update occurred in December 2005. However, there are 37 other studies that are currently recruiting patients."

Answered by AI
~31 spots leftby Mar 2025